134 related articles for article (PubMed ID: 27381421)
1. High Level of Anaphylatoxin C5a Predicts Poor Clinical Outcome in Patients with Clear Cell Renal Cell Carcinoma.
Xi W; Liu L; Wang J; Xia Y; Bai Q; Long Q; Wang Y; Xu J; Guo J
Sci Rep; 2016 Jul; 6():29177. PubMed ID: 27381421
[TBL] [Abstract][Full Text] [Related]
2. Enrichment of C5a-C5aR axis predicts poor postoperative prognosis of patients with clear cell renal cell carcinoma.
Xi W; Liu L; Wang J; Xia Y; Bai Q; Xiong Y; Qu Y; Long Q; Xu J; Guo J
Oncotarget; 2016 Dec; 7(49):80925-80934. PubMed ID: 27821813
[TBL] [Abstract][Full Text] [Related]
3. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma.
Laba P; Wang J; Zhang J
BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of CTR2 predicts poor prognosis of patients with clear cell renal cell carcinoma.
Xia Y; Liu L; Long Q; Bai Q; Wang J; Xu J; Guo J
Urol Oncol; 2016 Jan; 34(1):5.e1-9. PubMed ID: 26411550
[TBL] [Abstract][Full Text] [Related]
5. High CLEC-2 expression associates with unfavorable postoperative prognosis of patients with clear cell renal cell carcinoma.
Xiong Y; Liu L; Xia Y; Wang J; Xi W; Bai Q; Qu Y; Long Q; Xu J; Guo J
Oncotarget; 2016 Sep; 7(39):63661-63668. PubMed ID: 27564117
[TBL] [Abstract][Full Text] [Related]
6. High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma.
Xu Z; Liu Y; Yang Y; Wang J; Zhang G; Liu Z; Fu H; Wang Z; Liu H; Xu J
Oncotarget; 2017 Jan; 8(5):7548-7558. PubMed ID: 27911274
[TBL] [Abstract][Full Text] [Related]
7. P2X7 receptor predicts postoperative cancer-specific survival of patients with clear-cell renal cell carcinoma.
Liu Z; Liu Y; Xu L; An H; Chang Y; Yang Y; Zhang W; Xu J
Cancer Sci; 2015 Sep; 106(9):1224-31. PubMed ID: 26179886
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of UTX expression in patients with clear cell renal cell carcinoma.
Wang J; Liu L; Xi W; Long Q; Wang Y; Bai Q; Xia Y; Xu J; Guo J
Urol Oncol; 2016 Aug; 34(8):338.e19-27. PubMed ID: 27106782
[TBL] [Abstract][Full Text] [Related]
9. High Expression of Colony-Stimulating Factor 1 Receptor Associates with Unfavorable Cancer-Specific Survival of Patients with Clear Cell Renal Cell Carcinoma.
Yang L; Liu Y; An H; Chang Y; Zhang W; Zhu Y; Xu L; Xu J
Ann Surg Oncol; 2016 Mar; 23(3):1044-52. PubMed ID: 26467457
[TBL] [Abstract][Full Text] [Related]
10. High expression of interleukin-11 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma.
Pan D; Xu L; Liu H; Zhang W; Liu W; Liu Y; Fu Q; Xu J
Cancer Sci; 2015 May; 106(5):592-7. PubMed ID: 25702890
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte macrophage colony-stimulating factor predicts postoperative recurrence of clear-cell renal cell carcinoma.
Chang Y; Xu L; Zhou L; Fu Q; Liu Z; Yang Y; Lin Z; Xu J
Oncotarget; 2016 Apr; 7(17):24527-36. PubMed ID: 27016418
[TBL] [Abstract][Full Text] [Related]
12. Elevated Expression of N-Acetylgalactosaminyltransferase 10 Predicts Poor Survival and Early Recurrence of Patients with Clear-Cell Renal Cell Carcinoma.
Wu Q; Yang L; Liu H; Zhang W; Le X; Xu J
Ann Surg Oncol; 2015 Jul; 22(7):2446-53. PubMed ID: 25391266
[TBL] [Abstract][Full Text] [Related]
13. Dot1l expression predicts adverse postoperative prognosis of patients with clear-cell renal cell carcinoma.
Qu Y; Liu L; Wang J; Xi W; Xia Y; Bai Q; Xiong Y; Long Q; Xu J; Guo J
Oncotarget; 2016 Dec; 7(51):84775-84784. PubMed ID: 27713173
[TBL] [Abstract][Full Text] [Related]
14. IL-33 is associated with unfavorable postoperative survival of patients with clear-cell renal cell carcinoma.
Wang Z; Xu L; Chang Y; Zhou L; Fu H; Zhang W; Yang Y; Xu J
Tumour Biol; 2016 Aug; 37(8):11127-34. PubMed ID: 26926076
[TBL] [Abstract][Full Text] [Related]
15. CXC chemokine receptor 2 is associated with postoperative recurrence and survival of patients with non-metastatic clear-cell renal cell carcinoma.
An H; Xu L; Chang Y; Zhu Y; Yang Y; Chen L; Lin Z; Xu J
Eur J Cancer; 2015 Sep; 51(14):1953-61. PubMed ID: 26188847
[TBL] [Abstract][Full Text] [Related]
16. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K
Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
[TBL] [Abstract][Full Text] [Related]
17. High expression of galectin-7 associates with poor overall survival in patients with non-metastatic clear-cell renal cell carcinoma.
Wang J; Liu Y; Yang Y; Xu Z; Zhang G; Liu Z; Fu H; Wang Z; Liu H; Xu J
Oncotarget; 2016 Jul; 7(27):41986-41995. PubMed ID: 27259255
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of MUC3A is associated with poor prognosis in localized clear-cell renal cell carcinoma.
Niu T; Liu Y; Zhang Y; Fu Q; Liu Z; Wang Z; Fu H; Xu J; Liu K
Oncotarget; 2016 Aug; 7(31):50017-50026. PubMed ID: 27374181
[TBL] [Abstract][Full Text] [Related]
19. High Expression of Stearoyl-CoA Desaturase 1 Predicts Poor Prognosis in Patients with Clear-Cell Renal Cell Carcinoma.
Wang J; Xu Y; Zhu L; Zou Y; Kong W; Dong B; Huang J; Chen Y; Xue W; Huang Y; Zhang J
PLoS One; 2016; 11(11):e0166231. PubMed ID: 27861513
[TBL] [Abstract][Full Text] [Related]
20. Low CCL17 expression associates with unfavorable postoperative prognosis of patients with clear cell renal cell carcinoma.
Xiong Y; Liu L; Xia Y; Wang J; Xi W; Bai Q; Qu Y; Xu J; Guo J
BMC Cancer; 2017 Feb; 17(1):117. PubMed ID: 28178948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
